Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Machine learning analysis of MRI-derived texture features to predict placenta accreta spectrum in patients with placenta previa.

Romeo V, Ricciardi C, Cuocolo R, Stanzione A, Verde F, Sarno L, Improta G, Mainenti PP, D'Armiento M, Brunetti A, Maurea S.

Magn Reson Imaging. 2019 May 15. pii: S0730-725X(19)30277-2. doi: 10.1016/j.mri.2019.05.017. [Epub ahead of print]

PMID:
31102613
2.

The use of MSAP reveals epigenetic diversity of the invasive clonal populations of Arundo donax L.

Guarino F, Cicatelli A, Brundu G, Improta G, Triassi M, Castiglione S.

PLoS One. 2019 Apr 9;14(4):e0215096. doi: 10.1371/journal.pone.0215096. eCollection 2019.

3.

Lean thinking to improve emergency department throughput at AORN Cardarelli hospital.

Improta G, Romano M, Di Cicco MV, Ferraro A, Borrelli A, Verdoliva C, Triassi M, Cesarelli M.

BMC Health Serv Res. 2018 Dec 3;18(1):914. doi: 10.1186/s12913-018-3654-0.

4.

Early neutropenia with thrombocytopenia following alemtuzumab treatment for multiple sclerosis: case report and review of literature.

Maniscalco GT, Cerillo I, Servillo G, Napolitano M, Guarcello G, Abate V, Improta G, Florio C.

Clin Neurol Neurosurg. 2018 Dec;175:134-136. doi: 10.1016/j.clineuro.2018.11.002. Epub 2018 Nov 3.

PMID:
30419425
5.

Preliminary focus on the mechanical and antibacterial activity of a PMMA-based bone cement loaded with gold nanoparticles.

Russo T, Gloria A, De Santis R, D'Amora U, Balato G, Vollaro A, Oliviero O, Improta G, Triassi M, Ambrosio L.

Bioact Mater. 2017 May 15;2(3):156-161. doi: 10.1016/j.bioactmat.2017.05.002. eCollection 2017 Sep.

6.

Ovarian Clear Cell Carcinoma: From Morphology to Molecular Biology.

Improta G, Pettinato A, Høgdall E, Santeusanio G, Vatrano S, Fraggetta F, Zannoni GF.

Appl Immunohistochem Mol Morphol. 2018 Apr 7. doi: 10.1097/PAI.0000000000000662. [Epub ahead of print]

PMID:
29629954
7.

Use of the AHP methodology in system dynamics: Modelling and simulation for health technology assessments to determine the correct prosthesis choice for hernia diseases.

Improta G, Russo MA, Triassi M, Converso G, Murino T, Santillo LC.

Math Biosci. 2018 May;299:19-27. doi: 10.1016/j.mbs.2018.03.004. Epub 2018 Mar 5.

8.

Uncommon frame-shift exon 19 EGFR mutations are sensitive to EGFR tyrosine kinase inhibitors in non-small cell lung carcinoma.

Improta G, Zupa A, Natalicchio MI, Sisinni L, Marinaccio A, Bozza G, Vita G, Aieta M, Landriscina M.

Med Oncol. 2018 Jan 31;35(3):28. doi: 10.1007/s12032-018-1078-7.

PMID:
29387949
9.

Genetic characterization, micropropagation, and potential use for arsenic phytoremediation of Dittrichia viscosa (L.) Greuter.

Guarino F, Conte B, Improta G, Sciarrillo R, Castiglione S, Cicatelli A, Guarino C.

Ecotoxicol Environ Saf. 2018 Feb;148:675-683. doi: 10.1016/j.ecoenv.2017.11.010. Epub 2017 Nov 21.

PMID:
29172148
10.

Sentinel Node Biopsy in Melanoma: Lessons Learned From Different Positivity Rates From Different Hospitals.

Ferrara G, Improta G.

Ann Surg. 2017 Dec;266(6):e81. doi: 10.1097/SLA.0000000000001662. No abstract available.

PMID:
29136999
11.

Reducing the risk of healthcare-associated infections through Lean Six Sigma: The case of the medicine areas at the Federico II University Hospital in Naples (Italy).

Improta G, Cesarelli M, Montuori P, Santillo LC, Triassi M.

J Eval Clin Pract. 2018 Apr;24(2):338-346. doi: 10.1111/jep.12844. Epub 2017 Nov 3.

12.

Improving performances of the knee replacement surgery process by applying DMAIC principles.

Improta G, Balato G, Romano M, Ponsiglione AM, Raiola E, Russo MA, Cuccaro P, Santillo LC, Cesarelli M.

J Eval Clin Pract. 2017 Dec;23(6):1401-1407. doi: 10.1111/jep.12810. Epub 2017 Sep 26.

PMID:
28948662
13.

MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus invivo.

Improta G, Ritter C, Pettinato A, Vasta V, Schrama D, Fraggetta F, Becker JC.

J Cancer Res Clin Oncol. 2017 Aug;143(8):1489-1497. doi: 10.1007/s00432-017-2413-7. Epub 2017 Apr 12.

PMID:
28405827
14.

Effect of topical antiinflammatory drugs on mechanical behavior of rabbit cornea.

Lepore D, De Santis R, Pagliara MM, Gloria A, Oliviero O, Nucci C, Improta G, Triassi M, Ambrosio L.

J Appl Biomater Funct Mater. 2017 Apr 26;15(2):e142-e148. doi: 10.5301/jabfm.5000339.

15.

The application of Lean Six Sigma methodology to reduce the risk of healthcare-associated infections in surgery departments.

Montella E, Di Cicco MV, Ferraro A, Centobelli P, Raiola E, Triassi M, Improta G.

J Eval Clin Pract. 2017 Jun;23(3):530-539. doi: 10.1111/jep.12662. Epub 2016 Nov 18.

PMID:
27860065
16.

Epidermotropic progression of melanoma during therapy with vemurafenib and trametinib.

Ferrara G, Cacitti V, Improta G, Lo Re G, Corradin MT.

J Am Acad Dermatol. 2016 Oct;75(4):e133-e135. doi: 10.1016/j.jaad.2016.03.006. No abstract available. Erratum in: J Am Acad Dermatol. 2017 Jan;76(1):189.

PMID:
27646754
17.

FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases.

Zannoni GF, Improta G, Petrillo M, Pettinato A, Scambia G, Fraggetta F.

Oncol Lett. 2016 Aug;12(2):1159-1163. Epub 2016 Jun 14.

18.

Frequency and Time Domain Analysis of Foetal Heart Rate Variability with Traditional Indexes: A Critical Survey.

Romano M, Iuppariello L, Ponsiglione AM, Improta G, Bifulco P, Cesarelli M.

Comput Math Methods Med. 2016;2016:9585431. doi: 10.1155/2016/9585431. Epub 2016 Apr 18. Review.

19.

Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients.

Zannoni GF, Improta G, Pettinato A, Brunelli C, Troncone G, Scambia G, Fraggetta F.

J Clin Pathol. 2016 Dec;69(12):1088-1092. doi: 10.1136/jclinpath-2016-203776. Epub 2016 May 6.

PMID:
27153872
20.

Epidermal growth factor receptor exon 20 p.S768I mutation in non-small cell lung carcinoma: A case report combined with a review of the literature and investigation of clinical significance.

Improta G, Pettinato A, Gieri S, Scandurra G, Skovrider-Ruminski W, Høgdall E, Fraggetta F.

Oncol Lett. 2016 Jan;11(1):393-398. Epub 2015 Nov 5.

21.

Software for computerised analysis of cardiotocographic traces.

Romano M, Bifulco P, Ruffo M, Improta G, Clemente F, Cesarelli M.

Comput Methods Programs Biomed. 2016 Feb;124:121-37. doi: 10.1016/j.cmpb.2015.10.008. Epub 2015 Nov 5.

PMID:
26638805
22.

Long-term clinical results and MRI changes after autologous chondrocyte implantation in the knee of young and active middle aged patients.

Rosa D, Balato G, Ciaramella G, Soscia E, Improta G, Triassi M.

J Orthop Traumatol. 2016 Mar;17(1):55-62. doi: 10.1007/s10195-015-0383-6. Epub 2015 Oct 24.

23.

New developments in the management of advanced melanoma - role of pembrolizumab.

Improta G, Leone I, Donia M, Gieri S, Pelosi G, Fraggetta F.

Onco Targets Ther. 2015 Sep 14;8:2535-43. doi: 10.2147/OTT.S72823. eCollection 2015. Review.

24.

Lean Six Sigma: a new approach to the management of patients undergoing prosthetic hip replacement surgery.

Improta G, Balato G, Romano M, Carpentieri F, Bifulco P, Alessandro Russo M, Rosa D, Triassi M, Cesarelli M.

J Eval Clin Pract. 2015 Aug;21(4):662-72. doi: 10.1111/jep.12361. Epub 2015 May 11.

PMID:
25958776
25.

Maternal exposure to low levels of corticosterone during lactation protects against experimental inflammatory colitis-induced damage in adult rat offspring.

Petrella C, Giuli C, Agostini S, Bacquie V, Zinni M, Theodorou V, Broccardo M, Casolini P, Improta G.

PLoS One. 2014 Nov 18;9(11):e113389. doi: 10.1371/journal.pone.0113389. eCollection 2014.

26.

PIK3CA in ovarian clear cell carcinoma.

Zannoni GF, Improta G, Fraggetta F.

Hum Pathol. 2014 Dec;45(12):2514. doi: 10.1016/j.humpath.2014.07.023. Epub 2014 Aug 23. No abstract available.

PMID:
25245602
27.

Oral malignant melanoma: A report of two cases with BRAF molecular analysis.

Soma PF, Pettinato A, Agnone AM, Donia C, Improta G, Fraggetta F.

Oncol Lett. 2014 Sep;8(3):1283-1286. Epub 2014 Jul 4.

28.

Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma.

Zannoni GF, Improta G, Chiarello G, Pettinato A, Petrillo M, Scollo P, Scambia G, Fraggetta F.

Virchows Arch. 2014 Aug;465(2):193-8. doi: 10.1007/s00428-014-1599-1. Epub 2014 Jun 3.

PMID:
24889043
29.

Pyrosequencing evaluation of low-frequency KRAS mutant alleles for EGF receptor therapy selection in metastatic colorectal carcinoma.

Natalicchio MI, Improta G, Zupa A, Cursio OE, Stampone E, Possidente L, Teresa Gerardi AM, Vita G, Martini M, Cassano A, Piccoli C, Romito S, Aieta M, Antonetti R, Barone C, Landriscina M.

Future Oncol. 2014 Apr;10(5):713-23. doi: 10.2217/fon.13.233.

PMID:
24799053
30.

PSA nadir and outcome in 100 patients with pT3b prostate cancer.

Pepe P, Improta G, Fraggetta F, Emmanuele C, Simeon V, Dibenedetto G, Colecchia M, Aragona F.

Anticancer Res. 2014 Feb;34(2):937-41.

PMID:
24511036
31.

Prostate needle biopsy: what we do and what should be improved.

Fraggetta F, Pepe P, Improta G, Aragona F, Colecchia M.

Anal Quant Cytopathol Histpathol. 2013 Jun;35(3):130-8. Review.

PMID:
24344499
32.

Relaxant effect of proton pump inhibitors on in vitro myometrium from pregnant women.

Terranova C, Petrella C, Improta G, Severini C, Signore F, Damiani P, Plotti F, Scarpignato C, Angioli R.

Eur J Pharm Sci. 2014 Feb 14;52:125-31. doi: 10.1016/j.ejps.2013.10.007. Epub 2013 Nov 9.

PMID:
24215738
33.

Biological insights into BRAFV600 mutations in melanoma patient: Not mere therapeutic targets.

Improta G, Pelosi G, Tamborini E, Donia M, Santinami M, de Braud F, Fraggetta F.

Oncoimmunology. 2013 Aug 1;2(8):e25594. Epub 2013 Jul 3.

34.

Diagnostic consideration for sinonasal Wegener's granulomatosis clinically mistaken for carcinoma.

La Rosa C, Emmanuele C, Tranchina MG, Ippolito M, Cosentino S, Saita V, Improta G, Fraggetta F.

Case Rep Otolaryngol. 2013;2013:839451. doi: 10.1155/2013/839451. Epub 2013 Sep 9.

35.

Mechanisms of resistance to EGFR tyrosine kinase inhibitors gefitinib/erlotinib and to ALK inhibitor crizotinib.

Tartarone A, Lazzari C, Lerose R, Conteduca V, Improta G, Zupa A, Bulotta A, Aieta M, Gregorc V.

Lung Cancer. 2013 Sep;81(3):328-36. doi: 10.1016/j.lungcan.2013.05.020. Epub 2013 Jun 25. Review.

PMID:
23809060
36.

Poly (ADP-ribose) polymerase 1 protein expression in normal and neoplastic prostatic tissue.

Salemi M, Galia A, Fraggetta F, La Corte C, Pepe P, La Vignera S, Improta G, Bosco P, Calogero AE.

Eur J Histochem. 2013 Apr 15;57(2):e13. doi: 10.4081/ejh.2013.e13.

37.

Coexistence of two different mutations in codon 12 of the Kras gene in colorectal cancer: Report of a case supporting the concept of tumoral heterogeneity.

Improta G, Zupa A, Possidente L, Tartarone A, Pedicini P, Nappi A, Molinari S, Fraggetta F, Vita G.

Oncol Lett. 2013 May;5(5):1741-1743. Epub 2013 Mar 14.

38.

Prognostic decision support using symbolic dynamics in CTG monitoring.

Cesarelli M, Romano M, Bifulco P, Improta G, D'Addio G.

Stud Health Technol Inform. 2013;186:140-4.

PMID:
23542985
39.

Local tumor control probability to evaluate an applicator-guided volumetric-modulated arc therapy solution as alternative of 3D brachytherapy for the treatment of the vaginal vault in patients affected by gynecological cancer.

Pedicini P, Strigari L, Caivano R, Fiorentino A, Califano G, Nappi A, Improta G, Storto G, Cozzolino M, Chiumento C, Fusco V, Vavassori A, Benassi M, Orecchia R, Salvatore M.

J Appl Clin Med Phys. 2013 Mar 4;14(2):4075. doi: 10.1120/jacmp.v14i2.4075.

40.

Estimate of the accelerated proliferation by protein tyrosine phosphatase (PTEN) over expression in postoperative radiotherapy of head and neck squamous cell carcinoma.

Pedicini P, Fiorentino A, Improta G, Nappi A, Salvatore M, Storto G.

Clin Transl Oncol. 2013 Nov;15(11):919-24. doi: 10.1007/s12094-013-1024-2. Epub 2013 Mar 5.

PMID:
23460560
41.

Protective and worsening peripheral nociceptin/orphanin FQ receptor-mediated effect in a rat model of experimental colitis.

Petrella C, Giuli C, Broccardo M, Eutamene H, Cartier C, Leveque M, Bedini A, Spampinato S, Bueno L, Theodorou V, Improta G, Agostini S.

Pharmacol Res. 2013 Apr;70(1):72-9. doi: 10.1016/j.phrs.2013.01.004. Epub 2013 Jan 23.

PMID:
23353033
42.

Role of preeclampsia-related angiogenic factors in sunitinib cardiotoxicity: two cases and review of the literature.

Gallucci G, Tartarone A, Tocchetti CG, Bochicchio AM, Coccaro M, Capobianco A, Maurea N, Improta G, Zupa A, Aieta M.

Future Oncol. 2013 Jan;9(1):127-33. doi: 10.2217/fon.12.162. Review.

PMID:
23252570
43.

A pilot characterization of human lung NSCLC by protein pathway activation mapping.

Zupa A, Improta G, Silvestri A, Pin E, Deng J, Aieta M, Musto P, Nitti D, Mammano E, Liotta L, Belluco C, Wulfkuhle J, Petricoin E 3rd.

J Thorac Oncol. 2012 Dec;7(12):1755-1766. doi: 10.1097/JTO.0b013e3182725fc7.

44.

Correlation between EGFr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma.

Pedicini P, Nappi A, Strigari L, Jereczek-Fossa BA, Alterio D, Cremonesi M, Botta F, Vischioni B, Caivano R, Fiorentino A, Improta G, Storto G, Benassi M, Orecchia R, Salvatore M.

Radiat Oncol. 2012 Aug 24;7:143. doi: 10.1186/1748-717X-7-143. Review.

45.

An application of symbolic dynamics for FHRV assessment.

Cesarelli M, Romano M, Bifulco P, Improta G, D'Addio G.

Stud Health Technol Inform. 2012;180:123-7.

PMID:
22874165
46.

Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC.

Zupa A, Vita G, Landriscina M, Possidente L, Aieta M, Tartarone A, Improta G.

Med Oncol. 2012 Dec;29(5):3198-201. doi: 10.1007/s12032-012-0304-y. Epub 2012 Jul 8.

PMID:
22773041
47.

Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors.

Pedicini P, Caivano R, Jereczek-Fossa BA, Strigari L, Vischioni B, Alterio D, Cremonesi M, Botta F, Nappi A, Improta G, Storto G, Benassi M, Orecchia R.

Theor Biol Med Model. 2012 Jun 19;9:23. doi: 10.1186/1742-4682-9-23.

48.

TLQP-21, a VGF-derived peptide, stimulates exocrine pancreatic secretion in the rat.

Petrella C, Broccardo M, Possenti R, Severini C, Improta G.

Peptides. 2012 Jul;36(1):133-6. doi: 10.1016/j.peptides.2012.03.035. Epub 2012 Apr 24.

PMID:
22561241
49.

Assessment of glycemic control among diabetic residents in nursing homes.

Basso A, Peruzzi P, Carollo MC, Improta G, Fedeli U.

Diabetes Res Clin Pract. 2012 Jun;96(3):e80-3. doi: 10.1016/j.diabres.2012.02.026. Epub 2012 Mar 23.

PMID:
22445232
50.

Neuropeptide S inhibits stress-stimulated faecal output in the rat.

Petrella C, Agostini S, Guerrini R, Calò G, Giaquinto A, De Nuccio C, Improta G, Broccardo M.

Pharmacol Res. 2011 Nov;64(5):471-7. doi: 10.1016/j.phrs.2011.06.007. Epub 2011 Jun 17.

PMID:
21708257

Supplemental Content

Loading ...
Support Center